Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Amgen (AMGN)

Amgen Reports Third Quarter 2026 Financial Results and Reaffirms Guidance

Positive Impact 3 of 5 earnings

Amgen reported third-quarter 2026 financial results, showing an 8% increase in total revenues to $10.4 billion compared to the same period in 2025. GAAP earnings per share rose 19% to $7.08, while non-GAAP earnings per share grew 14% to $6.45.

Key points

  • Total revenues for the third quarter of 2026 increased 8% year-over-year to $10.4 billion.
  • GAAP earnings per share rose 19% to $7.08 for the third quarter of 2026.
  • Non-GAAP earnings per share increased 14% to $6.45 for the third quarter of 2026.
  • Full-year 2026 total revenues are expected to be in the range of $38.9 billion to $39.7 billion.

The filing

CompanyAmgen (AMGN)
Form8-K, current report
Filed with the SECNov 3, 2026, 4:05 PM ET
Accession number0000318154-26-000153

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 3, 2026, 4:16 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.